1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. PI3K
  4. PI3K Inhibitors

PI3K Inhibitors

PI3Kα

PI3Kβ

PI3Kγ

PI3Kδ

PI3KC2α

PI3KC2β

PI3KC2γ

Vps34

PI3K

PI3KC3

p120γ

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PI3K Inhibitors, Activators & Modulators
Product Name PI3Kα PI3Kβ PI3Kγ PI3Kδ PI3KC2α PI3KC2β PI3KC2γ Vps34 PI3K PI3KC3 p120γ Purity
Alpelisib
p110α, IC50: 5 nM
p110α-H1047R, IC50: 4 nM
p110α-E545K, IC50: 4 nM
p110β, IC50: 1200 nM
p110γ, IC50: 250 nM
p110δ, IC50: 290 nM
              99.95%
LY294002
p110α, IC50: 0.5 μM
p110β, IC50: 0.97 μM
 
p110δ, IC50: 0.57 μM
              99.95%
AZD-7648    
PI3Kγ, IC50: 1.37 μM
                99.89%
Buparlisib
p110α, IC50: 52 nM
p110α-H1047R, IC50: 58 nM
p110α-E545K, IC50: 99 nM
p110β, IC50: 166 nM
p110γ, IC50: 262 nM
p110δ, IC50: 116 nM
     
Vps34, IC50: 2.4 μM
      99.90%
Inavolisib
PI3Kα, IC50: 0.038 nM
                    99.72%
Leniolisib phosphate
PI3Kα, IC50: 280 nM
PI3Kβ, IC50: 480 nM
PI3Kγ, IC50: 2.57 nM
PI3Kδ, IC50: 11 nM
             
3-Methyladenine    
PtdIns3Kγ, IC50: 60 μM (Cell Assay)
       
Vps34, IC50: 25 μM (Cell Assay)
      99.91%
Copanlisib
PI3Kα, IC50: 0.5 nM
PI3Kβ, IC50: 3.7 nM
PI3Kγ, IC50: 6.4 nM
PI3Kδ, IC50: 0.7 nM
              99.50%
Wortmannin                
PI3K, IC50: 3 nM
    99.86%
Idelalisib
p110α, IC50: 820 nM
p110β, IC50: 565 nM
p110γ, IC50: 89 nM
p110δ, IC50: 2.5 nM
     
hVps34, IC50: 978 nM
      99.78%
Quercetin  
PI3Kβ, IC50: 5.4 μM
PI3Kγ, IC50: 3 μM
PI3Kδ, IC50: 2.4 μM
              98.03%
Pictilisib
p110α, IC50: 3 nM
p110α-H1047R, IC50: 3 nM
p110α-E545K, IC50: 3 nM
p110β, IC50: 33 nM
p110γ, IC50: 75 nM
p110δ, IC50: 3 nM
              99.80%
Dactolisib
p110α, IC50: 4 nM
p110α-H1047R, IC50: 4.6 nM
p110α-E545K, IC50: 5.7 nM
p110β, IC50: 75 nM
p110γ, IC50: 5 nM
p110δ, IC50: 7 nM
              99.94%
SAR405              
Vps34, IC50: 1.2 nM
Vps34, Kd: 1.5 nM
      98.99%
Eganelisib
PI3Kα, IC50: 3.2 μM
PI3Kβ, IC50: 3.5 μM
PI3Kγ, IC50: 16 nM
                99.69%
Duvelisib
p110α, IC50: 1602 nM
p110β, IC50: 85 nM
p110γ, IC50: 27.4 nM
p110δ, IC50: 2.5 nM
              99.89%
Omipalisib
p110α, Ki: 0.019 nM
p110α-H1047R, Ki: 0.009 nM
p110α-E545K, Ki: 0.008 nM
p110α-E542K, Ki: 0.008 nM
p110β, Ki: 0.13 nM
p110γ, Ki: 0.06 nM
p110δ, Ki: 0.024 nM
              99.93%
YM-201636
p110α, IC50: 3.3 μM
                    98.01%
Taselisib
PI3Kα, Ki: 0.29 nM
PI3Kβ, Ki: 9.1 nM
PI3Kγ, Ki: 0.97 nM
PI3Kδ, Ki: 0.12 nM
              99.86%
740 Y-P                
PI3K
    99.67%
Fimepinostat
PI3Kα, IC50: 19 nM
PI3Kβ, IC50: 54 nM
PI3Kγ, IC50: 311 nM
PI3Kδ, IC50: 39 nM
              99.95%
GSK2636771  
PI3Kβ, Ki: 0.89 nM
PI3Kβ, IC50: 5.2 nM
                  99.83%
Copanlisib dihydrochloride
PI3Kα, IC50: 0.5 nM
PI3Kβ, IC50: 3.7 nM
PI3Kγ, IC50: 6.4 nM
PI3Kδ, IC50: 0.7 nM
              99.55%
Umbralisib
PI3Kα, Kd: >10000 nM
PI3Kβ, Kd: >10000 nM
PI3Kγ, Kd: 1400 nM
PI3Kδ, EC50: 22.2 nM
PI3Kδ, Kd: 6.2 nM
              98.69%
Vps34-IN-1              
Vps34, IC50: 4 nM
      99.56%
Samotolisib
PI3Kα, IC50: 6.07 nM
PI3Kβ, IC50: 77.6 nM
PI3Kγ, IC50: 23.8 nM
PI3Kδ, IC50: 38 nM
              99.42%
PI-103
p110α, IC50: 8 nM
p110β, IC50: 88 nM
p110γ, IC50: 150 nM
p110δ, IC50: 48 nM
PI3KC2α, IC50: 1 μM
PI3KC2β, IC50: 26 nM
 
hsVPS34, IC50: 2.3 μM
      98.93%
PF-04691502
PI3Kα, Ki: 1.8 nM
PI3Kβ, Ki: 2.1 nM
PI3Kγ, Ki: 1.9 nM
PI3Kδ, Ki: 1.6 nM
              99.64%
AZD8186
PI3Kα, IC50: 35 nM
PI3Kβ, IC50: 4 nM
PI3Kγ, IC50: 675 nM
PI3Kδ, IC50: 12 nM
              99.97%
AS-605240
PI3Kα, IC50: 60 nM
PI3Kβ, IC50: 270 nM
PI3Kγ, IC50: 8 nM
PI3Kγ, Ki: 7.8 nM
PI3Kδ, IC50: 300 nM
              98.04%
Gedatolisib
PI3Kα, IC50: 0.4 nM
PI3Kα-H1047R, IC50: 0.6 nM
PI3Kα-E545K, IC50: 0.6 nM
PI3Kβ, IC50: 6 nM
PI3Kγ, IC50: 5.4 nM
PI3Kδ, IC50: 6 nM
              99.68%
Parsaclisib      
PI3Kδ, IC50: 1 nM
              99.31%
ZSTK474
PI3Kα, IC50: 16 nM
PI3Kβ, IC50: 44 nM
PI3Kγ, IC50: 49 nM
PI3Kδ, IC50: 4.6 nM
              99.88%
Voxtalisib
p110α, IC50: 39 nM
p110β, IC50: 113 nM
p110γ, IC50: 9 nM
p110δ, IC50: 43 nM
              98.81%
hSMG-1 inhibitor 11j
PI3Kα, IC50: 92 nM
 
PI3Kγ, IC50: 60 nM
                99.81%
TGX-221  
p110β, IC50: 8.5 nM
 
p110δ, IC50: 211 nM
              99.65%
Dactolisib Tosylate
p110α, IC50: 4 nM
p110α-H1047R, IC50: 4.6 nM
p110α-E545K, IC50: 5.7 nM
p110β, IC50: 75 nM
p110γ, IC50: 5 nM
p110δ, IC50: 7 nM
              99.88%
Serabelisib
p110α, IC50: 15 nM
p110β, IC50: 4500 nM
p110γ, IC50: 1900 nM
p110δ, IC50: 13900 nM
              99.21%
BGT226 maleate
PI3Kα, IC50: 4 nM
PI3Kβ, IC50: 63 nM
PI3Kγ, IC50: 38 nM
                99.87%
PIK-75 hydrochloride
p110α, IC50: 5.8 nM
p110β, IC50: 1.3 μM
p110γ, IC50: 76 nM
p110δ, IC50: 510 nM
PI3KC2α, IC50: 10 μM
PI3KC2β, IC50: 1 μM
 
hsVPS34, IC50: 2.6 μM
      99.72%
Sonolisib
p110α, IC50: 0.1 nM
   
p110δ, IC50: 2.9 nM
           
p120γ, IC50: 1 nM
99.00%
Bimiralisib
PI3Kα, IC50: 33 nM
PI3Kα-H1047R, IC50: 36 nM
PI3Kα-E545K, IC50: 136 nM
PI3Kα-E542K, IC50: 63 nM
PI3Kβ, IC50: 661 nM
PI3Kγ, IC50: 708 nM
PI3Kδ, IC50: 451 nM
     
Vps34, IC50: 6486 nM
      98.74%
AZD 6482
PI3Kα, IC50: 136 nM
PI3Kβ, IC50: 0.69 nM
PI3Kγ, IC50: 47.8 nM
PI3Kδ, IC50: 13.6 nM
 
PI3K-C2β, IC50: 54.1 nM
 
hVps34, IC50: 3390 nM
      99.56%
Apitolisib
PI3Kα, IC50: 5 nM
PI3Kβ, IC50: 27 nM
PI3Kγ, IC50: 14 nM
PI3Kδ, IC50: 7 nM
              99.65%
Nemiralisib
PI3Kα, pIC50: 5.3
PI3Kβ, pIC50: 5.8
PI3Kγ, pIC50: 5.2
PI3Kδ, pKi: 9.9
              99.80%
Vps34-PIK-III
PI(3)Kα, IC50: 3.96 μM
 
PI(3)Kγ, IC50: 3.04 μM
PI(3)Kδ, IC50: 1.2 μM
     
Vps34, IC50: 18 nM
      99.02%
VS-5584
PI3Kα, IC50: 16 nM
PI3Kβ, IC50: 68 nM
PI3Kγ, IC50: 25 nM
PI3Kδ, IC50: 42 nM
     
Vps34, IC50: 7470 nM
      98.15%
Quercetin dihydrate  
PI3Kβ, IC50: 5.4 μM
PI3Kγ, IC50: 2.4 μM
PI3Kδ, IC50: 3.0 μM
             
CNX-1351
PI3Kα, IC50: 6.8 nM
PI3Kβ, IC50: 166 nM
PI3Kγ, IC50: 3020 nM
PI3Kδ, IC50: 240.3 nM
              99.88%
Autophinib              
Vps34, IC50: 19 nM
      99.56%
α-Linolenic acid                
PI3K
    99.56%
CGS 15943    
p110γ, IC50: 1.1 μM
p110δ, IC50: 8.47 μM
              99.63%
A66
p110α, IC50: 32 nM
p110α E545K, IC50: 30 nM
p110α H1047R, IC50: 43 nM
 
p110γ, IC50: 3480 nM
   
PI3K-C2β, IC50: 462 nM
          99.68%
PI4KIIIbeta-IN-9
PI3Kα, IC50: 2 μM
 
PI3Kγ, IC50: 1046 nM
PI3Kδ, IC50: 152 nM
   
PI3KC2γ, IC50: 1 μM
        99.01%
Tenalisib    
PI3Kγ, IC50: 33 nM
PI3Kδ, IC50: 25 nM
              98.94%
PQR530
PI3Kα, Kd: 0.84 nM
PI3Kβ, Kd: 6.1 nM
PI3Kγ, Kd: 10 nM
PI3Kδ, Kd: 11 nM
 
PI3KC2β, Kd: 100 nM
          99.93%
PIK-93
p110α, IC50: 39 nM
p110β, IC50: 590 nM
p110γ, IC50: 16 nM
p110δ, IC50: 120 nM
PI3KC2α, IC50: 16 μM
PI3KC2β, IC50: 140 nM
 
hsVPS34, IC50: 320 nM
      99.81%
TG100-115    
PI3Kγ, IC50: 83 nM
PI3Kδ, IC50: 235 nM
              99.31%
PIK-90
p110α, IC50: 11 nM
p110β, IC50: 350 nM
p110γ, IC50: 18 nM
p110δ, IC50: 58 nM
PI3KC2α, IC50: 47 nM
PI3KC2β, IC50: 64 nM
 
hsVPS34, IC50: 830 nM
      99.70%
GSK1059615
PI3Kα, IC50: 0.4 nM
PI3Kβ, IC50: 0.6 nM
PI3Kγ, IC50: 2 nM
PI3Kδ, IC50: 5 nM
              ≥99.0%
AMG 511
PI3Kα, Ki: 4 nM
PI3Kβ, Ki: 6 nM
PI3Kγ, Ki: 1 nM
PI3Kδ, Ki: 2 nM
              99.38%
AZD-8835
PI3Kα, IC50: 6.2 nM
PI3Kα-E545K, IC50: 6 nM
PI3Kα-H1047R, IC50: 5.8 nM
PI3Kβ, IC50: 431 nM
PI3Kγ, IC50: 90 nM
PI3Kδ, IC50: 5.7 nM
              98.63%
GDC-0326
PI3Kα, Ki: 0.2 nM
PI3Kβ, Ki: 26.6 nM
PI3Kγ, Ki: 10.2 nM
PI3Kδ, Ki: 4 nM
              99.66%
Leniolisib
PI3Kα, IC50: 280 nM
PI3Kβ, IC50: 480 nM
PI3Kγ, IC50: 2.57 μM
PI3Kδ, IC50: 11 nM
              99.19%
Zandelisib      
PI3Kδ, IC50: 3.5 nM
              98.79%
Isorhamnetin                
PI3-K
    99.95%
SAR-260301
PI3Kα, IC50: 1539 nM
PI3Kβ, IC50: 23 nM
PI3Kγ, IC50: 10000 nM
PI3Kδ, IC50: 468 nM
   
PI3KC2γ, IC50: 3812 nM
Vps34, IC50: 183 nM
      99.37%
hSMG-1 inhibitor 11e
PI3Kα, IC50: 61 nM
 
PI3Kγ, IC50: 92 nM
                99.18%
Recilisib                
PI3K
    99.14%
Pilaralisib
PI3Kα, IC50: 39 nM
PI3Kβ, IC50: 383 nM
PI3Kγ, IC50: 23 nM
PI3Kδ, IC50: 36 nM
     
Vps34, IC50: 6974 nM
      99.69%
AMG319
PI3Kα, IC50: 33 μM
PI3Kβ, IC50: 2.7 μM
PI3Kγ, IC50: 850 nM
PI3Kδ, IC50: 18 nM
              98.27%
MTX-211                
PI3K
    ≥98.0%
BAY1082439
PI3Kα
PI3Kβ
 
PI3Kδ
              99.46%
Acalisib
p110α, IC50: 5441 nM
p110β, IC50: 3377 nM
p110γ, IC50: 1389 nM
p110δ, IC50: 12.7 nM
     
hVps34, IC50: 12682 nM
      99.98%
SF2523
PI3Kα, IC50: 34 nM
 
PI3Kγ, IC50: 158 nM
               
Izorlisib
PI3Kα, IC50: 14 nM
PI3Kα-H1047R, IC50: 5.6 nM
PI3Kα-E545K, IC50: 6.7 nM
PI3Kα-E542K, IC50: 6.7 nM
PI3Kβ, IC50: 120 nM
PI3Kγ, IC50: 36 nM
PI3Kδ, IC50: 500 nM
 
PI3KC2β, IC50: 5.3 μM
          98.81%
AS-252424
PI3Kα, IC50: 935 nM
PI3Kβ, IC50: 20 μM
PI3Kγ, IC50: 30 nM
PI3Kδ, IC50: 20 μM
              99.71%
Duvelisib (R enantiomer)                
PI3K
   
NSC781406
PI3Kα, IC50: 2 nM
PI3Kβ, IC50: 9.4 nM
PI3Kγ, IC50: 2.7 nM
PI3Kδ, IC50: 14 nM
              99.91%
HS-173
PI3Kα, IC50: 0.8 nM
                    99.04%
AZD3458
PI3Kα, pIC50: 5.1
PI3Kβ, pIC50: 4.5
PI3Kγ, pIC50: 9.1
PI3Kδ, pIC50: 6.5
PI3KC2α, pIC50: 5
PI3KC2β, pIC50: 7.5
PI3KC2γ, pIC50: 5.5
   
PI3KC3, pIC50: 5.1
  99.82%
Pictilisib dimethanesulfonate
p110α, IC50: 3 nM
p110α-H1047R, IC50: 3 nM
p110α-E545K, IC50: 3 nM
p110β, IC50: 33 nM
p110γ, IC50: 75 nM
p110δ, IC50: 3 nM
              99.31%
KU-0060648
PI3Kα, IC50: 4 nM
PI3Kβ, IC50: 0.5 nM
PI3Kγ, IC50: 0.594 μM
PI3Kδ, IC50: 0.1 nM
              99.39%
PI3K/AKT-IN-1    
PI3Kγ, IC50: 6.99 μM
PI3Kδ, IC50: 4.01 μM
              99.62%
PI-103 Hydrochloride
p110α, IC50: 2 nM
p110β, IC50: 3 nM
p110γ, IC50: 15 nM
p110δ, IC50: 3 nM
              98.00%
Buparlisib Hydrochloride
p110α, IC50: 52 nM
p110α-H1047R, IC50: 58 nM
p110α-E545K, IC50: 99 nM
p110β, IC50: 166 nM
p110γ, IC50: 262 nM
p110δ, IC50: 116 nM
     
Vps34, IC50: 2.4 μM
      99.88%
IC-87114  
PI3Kβ, IC50: 75 μM
PI3Kγ, IC50: 29 μM
PI3Kδ, IC50: 0.5 μM
              99.83%
Seletalisib      
PI3Kδ, IC50: 12 nM
              98.88%
CAY10505    
PI3Kγ, IC50: 30 nM (Neurons)
                99.75%
PI3K/mTOR Inhibitor-2
PI3Kα, IC50: 3.4 nM
PI3Kβ, IC50: 34 nM
PI3Kγ, IC50: 1 nM
PI3Kδ, IC50: 16 nM
              98.25%
Flupentixol dihydrochloride
PI3Kα, IC50: 127 nM
                    99.73%
Esculetin                
PI3K
    99.59%
PI-828
p110α, IC50: 173 nM
                    99.09%
1,3-Dicaffeoylquinic acid                
PI3K
    98.85%
GNE-317                
PI3K
    99.31%
LX2343                
PI3K, IC50: 15.99 μM
    99.80%
PF-04979064
PI3Kα, Ki: 0.13 nM
 
PI3Kγ, Ki: 0.111 nM
PI3Kδ, Ki: 0.122 nM
              99.83%
CZC24832  
PI3Kβ, IC50: 1.1 μM
PI3Kγ, IC50: 27 nM
PI3Kδ, IC50: 8.194 μM
              99.35%
TG 100713
PI3Kα, IC50: 165 nM
PI3Kβ, IC50: 215 nM
PI3Kγ, IC50: 50 nM
PI3Kδ, IC50: 24 nM
              99.49%
Dihydrocapsaicin                
PI3K
    99.86%
TASP0415914    
PI3Kγ, IC50: 29 nM
                99.37%
WYE-687
PI3K alpha, IC50: 81 nM
 
PI3K gamma, IC50: 3.11 μM
                98.10%
Brevianamide F
PI3Kα, IC50: 4.8 μM
                    99.30%
Linperlisib      
PI3Kδ, IC50: 6.4 nM
              99.51%
CYH33 methanesulfonate
PI3Kα, IC50: 5.9 nM
PI3Kβ, IC50: 598 nM
PI3Kγ, IC50: 225 nM
PI3Kδ, IC50: 78.7 nM
             
Parsaclisib hydrochloride      
PI3Kδ, IC50: 1 nM
              98.74%
Pilaralisib analogue
PI3K-alpha
                    99.67%
MSC2360844
PI3Kα, IC50: 18500 nM
PI3Kβ, IC50: 2850 nM
 
PI3Kδ, IC50: 145 nM
              99.96%
Risovalisib
PI3Kα, IC50: 5.9 nM
PI3Kβ, IC50: 598 nM
PI3Kγ, IC50: 225 nM
PI3Kδ, IC50: 78.7 nM
              99.39%
IPI-3063
p110α, IC50: 1170 nM
p110β, IC50: 1508 nM
p110γ, IC50: 2187 nM
p110δ, IC50: 2.5 nM
              99.22%
ETP-45658
PI3Kα, IC50: 22.0 nM
PI3Kβ, IC50: 129.0 nM
PI3Kγ, IC50: 717.3 nM
PI3Kδ, IC50: 39.8 nM
              98.05%
PKI-179 hydrochloride
PI3Kα, IC50: 8 nM
PI3Kβ, IC50: 24 nM
PI3Kγ, IC50: 74 nM
PI3Kδ, IC50: 77 nM
              98.11%
PKI-179
PI3Kα, IC50: 8 nM
PI3Kβ, IC50: 24 nM
PI3Kγ, IC50: 74 nM
PI3Kδ, IC50: 77 nM
              ≥98.0%
Sophocarpine                
PI3K
    98.63%
PIK-293
PI3Kα, IC50: 100 μM
PI3Kβ, IC50: 10 μM
PI3Kγ, IC50: 25 μM
PI3Kδ, IC50: 0.24 μM
              98.55%
PI3K/mTOR Inhibitor-4
PI3Kα, IC50: 0.63 nM
PI3Kβ, IC50: 94.54 nM
PI3Kγ, IC50: 22 nM
PI3Kδ, IC50: 9.2 nM
             
AZ2
PI3Kα, pIC50: 5.1
PI3Kβ, pIC50: 4.5
PI3Kγ, pIC50: 9.3
PI3Kδ, pIC50: 6.6
              99.38%
PKI-402
PI3Kα, IC50: 2 nM
PI3Kα-H1047R, IC50: 3 nM
PI3Kα-E545K, IC50: 3 nM
PI3Kβ, IC50: 7 nM
PI3Kγ, IC50: 16 nM
PI3Kδ, IC50: 14 nM
              98.43%
PI-3065
p110α, IC50: 910 nM
p110β, IC50: 600 nM
 
p110δ, IC50: 5 nM
              98.97%
GNE-490
PI3Kα, IC50: 3.5 nM
PI3Kβ, IC50: 25 nM
PI3Kγ, IC50: 15 nM
PI3Kδ, IC50: 5.2 nM
             
Vps34-IN-2              
Vps34, IC50: 2 nM
      99.74%
BGT226
PI3Kα, IC50: 4 nM
PI3Kβ, IC50: 63 nM
PI3Kγ, IC50: 38 nM
                99.51%
Umbralisib hydrochloride
PI3Kα, Kd: >10000 nM
PI3Kβ, Kd: >10000 nM
PI3Kγ, Kd: 1400 nM
PI3Kδ, EC50: 22.2 nM
PI3Kδ, Kd: 6.2 nM
              98.98%
MSC2360844 hemifumarate      
PI3Kδ, IC50: 145 nM
              99.95%
PI3Kα-IN-4
PI3Kα, IC50: 1.8 nM
                    99.83%
PF-06843195
PI3Kα, IC50: 18 nM (in Rat1 fibroblasts)
PI3Kα, Ki: 0.018 nM
PI3Kβ, IC50: 360 nM (in Rat1 fibroblasts)
 
PI3Kδ, IC50: 160 nM (in Rat1 fibroblasts)
PI3Kδ, Ki: 0.28 nM
              99.06%
(S)-PI3Kα-IN-4
PI3Kα, IC50: 2.3 nM
                    99.79%
SRX3207
PI3Kα, IC50: 861 nM
 
PI3Kγ, IC50: 11100 nM
PI3Kδ, IC50: 1280 nM
              98.92%
Vulolisib
PI3Kα, IC50: 0.2 nM
PI3Kβ, IC50: 168 nM
PI3Kγ, IC50: 90 nM
PI3Kδ, IC50: 49 nM
             
AZD8154    
PI3Kγ
                99.69%
IITZ-01    
PI3Kγ, IC50: 2.62 μM
                99.05%
Sophocarpine monohydrate                
PI3K
    99.15%
AQX-016A                
PI3K
    98.00%
AS-604850
PI3Kα, IC50: 4.5 μM
 
PI3Kγ, IC50: 0.25 μM
PI3Kγ, Ki: 0.18 μM
                99.91%
BEBT-908
PI3Kα, IC50: 0.1 μM
                    99.14%
Hederacolchiside A1                
PI3K
    99.69%
NVS-PI3-4    
PI3Kγ
                99.74%
PI3K-IN-31
PI3Kα, IC50: 3.7 nM
PI3Kβ, IC50: 74 nM
PI3Kγ, IC50: 14.6 nM
PI3Kδ, IC50: 9.9 nM
              99.55%
PF-4989216
PI3Kα, Ki: 0.6 nM
                    99.69%
YH-306                
PI3K
    98.01%
Polygalasaponin F                
PI3K
    99.74%
AS-041164
PI3Kα, IC50: 240 nM
PI3Kβ, IC50: 1.4 μM
PI3Kγ, IC50: 70 nM
PI3Kδ, IC50: 1.7 μM
              99.32%
Arnicolide D                
PI3K
    99.20%
PI3K-IN-1                
PI3K
    99.93%
Glaucocalyxin A                
PI3K
    99.38%
GSK-F1                
PI3KA, pIC50: 5.8
PI3KB, pIC50: 5.9
PI3KG, pIC50: 5.9
PI3KD, pIC50: 6.4
   
GNE-477
PI3Kα, IC50: 4 nM
                    98.70%
NVP-BAG956
PI3Kα, IC50: 56 nM
PI3Kβ, IC50: 446 nM
PI3Kγ, IC50: 117 nM
PI3Kδ, IC50: 35 nM
              99.12%
ETP-46321
p110α, Ki: 2.3 nM
PI3Kα-H1047R, Ki: 2.33 nM
PI3Kα-E545K, Ki: 1.77 nM
PI3Kα-E542K, Ki: 1.89 nM
p110β, Ki: 170 nM
p110γ, Ki: 179 nM
p110δ, Ki: 14.2 nM
              99.65%
NVP-QAV-572                
PI3K, IC50: 10 nM
    98.05%
GNE-493
PI3Kα, IC50: 3.4 nM
PI3Kβ, IC50: 12 nM
PI3Kγ, IC50: 16 nM
PI3Kδ, IC50: 16 nM
              98.33%
CAL-130 Hydrochloride
p110α, IC50: 115 nM
p110β, IC50: 56 nM
p110γ, IC50: 6.1 nM
p110δ, IC50: 1.3 nM
              98.74%
PIK-294
p110α, IC50: 10 μM
p110β, IC50: 490 nM
p110γ, IC50: 160 nM
p110δ, IC50: 10 nM
              99.90%
GS-9901      
PI3Kδ, IC50: 1 nM
             
Umbralisib tosylate
PI3Kα, Kd: >10000 nM
PI3Kβ, Kd: >10000 nM
PI3Kγ, Kd: 1400 nM
PI3Kδ, Kd: 6.2 nM
             
Umbralisib sulfate
PI3Kα, Kd: >10000
PI3Kβ, Kd: >10000
PI3Kγ, Kd: 1400
PI3Kδ, Kd: 6.2
             
PI3K/mTOR Inhibitor-11
PI3Kα, IC50: 3.5 nM
   
PI3Kδ, IC50: 4.6 nM
              98.74%
PI3K/HDAC-IN-1
PI3Kα, IC50: 42 nM
PI3Kβ, IC50: 101 nM
PI3Kγ, IC50: 67 nM
PI3Kδ, IC50: 8.1 nM
             
PI3K/mTOR Inhibitor-1
PI3Kα, IC50: 20 nM
PI3Kβ, IC50: 376 nM
PI3Kγ, IC50: 204 nM
PI3Kδ, IC50: 46 nM
             
IHMT-PI3Kδ-372      
PI3Kδ, IC50: 14 nM
              99.75%
PI3K-IN-6
PI3Kα, IC50: 850 nM
PI3Kβ, IC50: 7.8 nM
 
PI3Kδ, IC50: 5.3 nM
             
PI3Kδ-IN-8
PI3Kα, IC50: 377.2 nM
PI3Kβ, IC50: 241.6 nM
PI3Kγ, IC50: 17.9 nM
PI3Kδ, IC50: 3.3 nM
             
FD223
PI3Kα, IC50: 51 nM
PI3Kβ, IC50: 29 nM
PI3Kγ, IC50: 37 nM
PI3Kδ, IC50: 1 nM
              98.68%
PI3Kγ inhibitor 2    
PI3Kγ, Ki: 4 nM
               
PI3Kdelta inhibitor 1      
PI3Kδ, IC50: 1.3 nM
             
PARP/PI3K-IN-1
PI3Kα, pIC50: 8.25
PI3Kβ, pIC50: 6.54
PI3Kγ, pIC50: 6.08
PI3Kδ, pIC50: 8.13
             
LAS191954      
PI3Kδ, IC50: 2.6 nM
             
PI3K-IN-9      
PI3Kδ
             
CHMFL-PI3KD-317
PI3Kα, IC50: 62.6 nM
PI3Kβ, IC50: 284 nM
PI3Kγ, IC50: 202.7 nM
PI3Kδ, IC50: 6 nM
 
PIK3C2B, IC50: 882.3 nM
 
Vps34, IC50: 1801.7 nM
      98.04%
PI3Kγ inhibitor 4
PI3Kα, IC50: 300 nM
 
PI3Kγ, IC50: 40 nM
               
PI3K-IN-2
PI3Kα, IC50: 13 nM
PI3Kβ, IC50: 7.1 nM
PI3Kγ, IC50: 8.6 nM
PI3Kδ, IC50: 190 nM
             
PI3Kα-IN-6
PI3Kα
                   
PI3K-IN-37
PI3Kα, IC50: 6 nM
PI3Kβ, IC50: 8 nM
 
PI3Kδ, IC50: 4 nM
             
PI3K/mTOR Inhibitor-9
PI3Kα, IC50: 6.6 μM
PI3Kβ, IC50: >10 μM
PI3Kγ, IC50: 6.6 μM
PI3Kδ, IC50: 0.8 μM
             
PI3K-IN-33
PI3Kα, IC50: 11.73 μM
PI3Kβ, IC50: 6.09 μM
 
PI3Kδ, IC50: 11.18 μM
             
PI3K-IN-22
PI3Kα, IC50: 0.9 nM
                   
PI3Kδ-IN-10      
PI3Kδ, IC50: 2 nM
             
ATM Inhibitor-3                
PI3K
   
PI3K-IN-30
PI3Kα, IC50: 5.1 nM
PI3Kβ, IC50: 136 nM
PI3Kγ, IC50: 30.7 nM
PI3Kδ, IC50: 8.9 nM
             
PI3Kδ-IN-11      
PI3Kδ, IC50: 27.5 nM
             
PI3K-IN-38
p110α, IC50: 0.541 μM
                   
NVP-CLR457
PI3Kα, IC50: 12 ± 1.5 nM
PI3Kβ, IC50: 8.3 ± 1.0 nM
PI3Kγ, IC50: 230 ± 31 nM
PI3Kδ, IC50: 8.3 ± 2.0 nM
             
TGX-155  
PI3Kβ
                 
PI3K-IN-34
PI3Kα, IC50: 8.43 μM
PI3Kβ, IC50: 15.84 μM
 
PI3Kδ, IC50: 30.62 μM
             
ATM Inhibitor-4                
PI3K
   
PI3K/HDAC-IN-2
PI3Kα, IC50: 226 nM
PI3Kβ, IC50: 279 nM
PI3Kγ, IC50: 467 nM
PI3Kδ, IC50: 29 nM
             
PI3K/mTOR Inhibitor-3                
PI3K
   
PI3Ka-IN-5
PI3Kα, IC50: 0.7 nM
                   
WYE-687 dihydrochloride
PI3K alpha, IC50: 81 nM
 
PI3K gamma, IC50: 3.11 μM
                ≥98.0%
PP30    
p110γ, IC50: 0.68 μM
p110δ, IC50: 0.99 μM
             
PI3Kα-IN-9
PI3Kα, IC50: 4.4 nM
PI3Kβ, IC50: 153 nM
PI3Kγ, IC50: 128 nM
PI3Kδ, IC50: 146 nM
             
PI3Kα-IN-5
PI3Kα, IC50: 0.7 nM
PI3Kβ, IC50: 4.3 nM
PI3Kγ, IC50: 8.7 nM
PI3Kδ, IC50: 27.4 nM
             
CHMFL-PI4K-127
PI3Kα, IC50: 191 ± 36 nM
PI3Kβ, IC50: 392 ± 27 nM
PI3Kγ, IC50: 324 ± 19 nM
PI3Kδ, IC50: 104 ± 3 nM
     
Vps34, IC50: 681 ± 25 nM
     
GSK2292767      
PI3Kδ, pIC50: 10.1
             
PI3K/mTOR Inhibitor-12
PI3Kα, IC50: 0.06 nM
                   
Umbralisib R-enantiomer      
PI3Kδ
              99.52%
COX-2/PI3K-IN-2                
PI3K, IC50: 2.78 nM
   
MEK/PI3K-IN-2
PI3Kα, IC50: 107 ± 21 nM
PI3Kβ, IC50: 3880 ± 725 nM
PI3Kγ, IC50: 2567 ± 364 nM
PI3Kδ, IC50: 137 ± 7 nM
             
ATR-IN-15                
PI3K, IC50: 5131 nM
   
PI3Kδ/γ-IN-3    
PI3Kγ, IC50: 16 nM
PI3Kδ, IC50: 1 nM
             
PI3Kα-IN-7
PI3Kα
PI3Kβ
                 
PI3K-IN-35
PI3Kα, IC50: 13.98 μM
PI3Kβ, IC50: 7.22 μM
 
PI3Kδ, IC50: 10.94 μM
             
MEK/PI3K-IN-1
PI3Kα, IC50: 130 ± 13 nM
PI3Kβ, IC50: 1537 ± 188 nM
PI3Kγ, IC50: 2745 ± 485 nM
PI3Kδ, IC50: 236 ± 29 nM
             
PI3K/mTOR Inhibitor-8
PI3Kα, IC50: 0.46 nM
                   
Flupentixol
PI3Kα, IC50: 127 nM
                   
PI3Kδ-IN-12
PI3Kα, pKi: 6.7
PI3Kβ, pKi: 6.4
PI3Kγ, pKi: 6.5
PI3Kδ, pIC50: 5.8
PI3Kδ, pKi: 8.0
             
PIK-75
p110α, IC50: 5.8 nM
p110β, IC50: 1.3 μM
p110γ, IC50: 76 nM
p110δ, IC50: 510 nM
PI3KC2α, IC50: 10 μM
PI3KC2β, IC50: 1 μM
 
hsVPS34, IC50: 2.6 μM
     
CXJ-2                
PI3K
   
COX-2/PI3K-IN-1                
PI3K, IC50: 1.14 nM
   
Gilmelisib
p110α, IC50: <1 nM
                    99.62%
PI3Kδ/γ-IN-2    
PI3Kγ, IC50: 4.3 nM
PI3Kδ, IC50: 1 nM
             
PI3K-IN-10                
PI3K
   
PI3Kα-IN-8
PI3Kα, IC50: 0.012 μM
PI3Kβ, IC50: 0.21 μM
PI3Kγ, IC50: 0.18 μM
PI3Kδ, IC50: 0.11 μM
             
PI3K/VEGFR2-IN-1                
PI3K, IC50: 2.21 μM
   
Topoisomerase I/II inhibitor 3                
PI3K
   
PI3Kγ inhibitor 1
PI3Kα, IC50: 10 μM
PI3Kβ, IC50: 10 μM
PI3Kγ, IC50: 100 nM
PI3Kδ, IC50: 100 nM
             
CAL-130 Racemate      
PI3Kδ
             
ON 146040
PI3Kα, IC50: 14 nM
PI3Kβ, IC50: 3 μM
PI3Kγ, IC50: 1 μM
PI3Kδ, IC50: 20 nM
             
CAL-130
p110α, IC50: 115 nM
p110β, IC50: 56 nM
p110γ, IC50: 6.1 nM
p110δ, IC50: 1.3 nM
             
PI3kδ inhibitor 1      
PI3Kδ, IC50: 3.8 nM
             
PI3Kα/mTOR-IN-1
PI3Kα, Ki: 12.5 nM
PI3Kα, IC50: 7 nM (Cell Assay)